Otsuka Holdings Co., Ltd.

General ticker "OTSKF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $30.0B (TTM average)

Otsuka Holdings Co., Ltd. follows the US Stock Market performance with the rate: 31.5%.

Estimated limits based on current volatility of 0.1%: low 64.04$, high 64.22$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-12-31, amount 0.45$ (Y0.70%)
  • Earnings for 15 months up through Q1 (+1 year) are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [46.13$, 65.75$]
  • 2025-12-31 to 2026-12-31 estimated range: [50.78$, 71.52$]

Financial Metrics affecting the OTSKF estimates:

  • Negative: with PPE of 13.8 at the end of fiscal year the price was high
  • Positive: 6.59 < Operating cash flow per share per price, % of 7.32
  • Positive: 7.54 < Operating profit margin, % of 13.89
  • Positive: Shareholder equity ratio, % of 73.11 > 64.29
  • Positive: Return on assets ratio (scaled to [-100,100]) of 8.40 > 6.06
  • Positive: Industry earnings per price (median), % of 5.35 > 4.45
  • Positive: 5.46 < Industry operating cash flow per share per price (median), % of 7.82
  • Positive: Industry operating profit margin (median), % of 20.58 > 9.60

Similar symbols

Short-term OTSKF quotes

Long-term OTSKF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue ¥1,737,998.00MM ¥2,018,568.00MM ¥2,329,861.00MM
Operating Expenses ¥1,587,675.00MM ¥1,878,956.00MM ¥2,006,297.00MM
Operating Income ¥150,323.00MM ¥139,612.00MM ¥323,564.00MM
Non-Operating Income ¥22,631.00MM ¥3,043.00MM ¥12,290.00MM
Interest Expense ¥6,063.00MM ¥6,523.00MM ¥8,791.00MM
R&D Expense ¥275,230.00MM ¥307,804.00MM ¥314,233.00MM
Income(Loss) ¥172,954.00MM ¥142,655.00MM ¥335,854.00MM
Taxes ¥35,534.00MM ¥17,155.00MM ¥-11,417.00MM
Net Income(Loss)* ¥133,906.00MM ¥121,616.00MM ¥343,120.00MM
Stockholders Equity ¥2,225,407.00MM ¥2,393,683.00MM ¥2,733,580.00MM
Inventory ¥223,507.00MM ¥249,581.00MM ¥298,292.00MM
Assets ¥3,102,716.00MM ¥3,361,244.00MM ¥3,739,251.00MM
Operating Cash Flow ¥211,848.00MM ¥283,232.00MM ¥354,638.00MM
Capital expenditure ¥107,787.00MM ¥114,673.00MM ¥129,362.00MM
Investing Cash Flow ¥-81,575.00MM ¥-190,538.00MM ¥-265,793.00MM
Financing Cash Flow ¥-95,474.00MM ¥-60,168.00MM ¥-189,367.00MM
Earnings Per Share** ¥246.81 ¥224.10 ¥633.77

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.